#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13694	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2203	618.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1413	1413	C	791	C	711	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24792	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3355	735.7	0	.	n	.	0	T695C	SNP	695	695	T	924	924	C	743	C,T	652,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24792	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3355	735.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1867	1867	G	818	G	735	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24792	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3355	735.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2200	2200	C	804	C,T	712,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24792	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3355	735.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2274	2274	A	772	A	699	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24792	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3355	735.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2826	2826	C	732	C	661	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1910	folP	855	855	100.0	folP.l15.c30.ctg.1	1399	135.9	1	SNP	p	R229S	1	.	.	685	687	AGC	969	971	AGC	179;175;176	A;G;C,A	162;159;155,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4792	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	139.4	1	SNP	p	S91F	1	.	.	271	273	TTC	612	614	TTC	169;169;169	T;T;C	153;152;152	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4792	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	139.4	1	SNP	p	G95N	0	.	.	283	285	GGC	624	626	GGC	165;163;163	G;G;C	152;147;147	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4792	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	139.4	1	SNP	p	D95G	1	.	.	283	285	GGC	624	626	GGC	165;163;163	G;G;C	152;147;147	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1526	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1149	132.3	1	SNP	p	G45D	0	.	.	133	135	GGC	384	386	GGC	197;194;191	G;G;C	182;178;176	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	728	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	931	78.0	0	.	n	.	0	A197.	DEL	197	197	A	509	509	A	185	A	170	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5012	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2900	172.5	1	SNP	p	D86N	0	.	.	256	258	GAC	509	511	GAC	213;210;211	G;A;C	192;182;189	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5012	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2900	172.5	1	SNP	p	R87W	0	.	.	259	261	CGT	512	514	CGT	212;209;209	C;G;T	193;192;190	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5012	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2900	172.5	1	SNP	p	R87I	0	.	.	259	261	CGT	512	514	CGT	212;209;209	C;G;T	193;192;190	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5012	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2900	172.5	1	SNP	p	S87R	1	.	.	259	261	CGT	512	514	CGT	212;209;209	C;G;T	193;192;190	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5012	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2900	172.5	1	SNP	p	S88P	0	.	.	262	264	TCC	515	517	TCC	209;211;212	T;C;C	189;190;192	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4050	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2671	151.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1541	1543	GGC	201;200;201	G;G;C	181;180;180	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1180	1182	GCC	229;228;226	G,A;C;C	204,1;203;201	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1183	1185	ATG	228;227;227	A;T;G	205;205;202	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1195	1197	ACC	216;220;221	A;C;C,A	191;200;198,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1195	1197	ACC	216;220;221	A;C;C,A	191;200;198,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1696	1698	ACC	216;217;218	A,T;C;C	185,1;194;195	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1750	1752	GCG	222;221;221	G;C;G,A	196;195;194,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1750	1752	GCG	222;221;221	G;C;G,A	196;195;194,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1873	1875	GGT	186;184;183	G;G;T	158;156;158	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1882	1884	AGC	177;178;175	A;G;C	158;160;152	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3978	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	172.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1900	1902	CCG	149;152;156	C,G;C;G	115,3;115;121	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5342	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2958	180.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1568	1570	CCG	196;198;196	C;C;G,A	166;171;166,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2204	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1783	123.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	535	535	C	139	C	123	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2770	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1617	170.5	1	SNP	p	G120K	1	.	.	358	360	AAG	690	692	AAG	227;228;228	A;A;G	201;206;197	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2770	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1617	170.5	1	SNP	p	N121D	0	.	.	361	363	AAC	693	695	AAC	231;232;233	A,G;A,G;C	203,1;206,1;206	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2770	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1617	170.5	1	SNP	p	A121N	1	.	.	361	363	AAC	693	695	AAC	231;232;233	A,G;A,G;C	203,1;206,1;206	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10506	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4741	220.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1154	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	894	128.4	1	SNP	p	V57M	1	.	.	169	171	ATG	460	462	ATG	248;249;249	A;T;G	227;232;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
